These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 9710959

  • 1. Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes.
    Heo Y, Lee WT, Lawrence DA.
    Toxicol Sci; 1998 Jun; 43(2):172-85. PubMed ID: 9710959
    [Abstract] [Full Text] [Related]

  • 2. Posttranscriptional inhibition of interferon-gamma production by lead.
    Heo Y, Mondal TK, Gao D, Kasten-Jolly J, Kishikawa H, Lawrence DA.
    Toxicol Sci; 2007 Mar; 96(1):92-100. PubMed ID: 17164472
    [Abstract] [Full Text] [Related]

  • 3. Lead differentially modifies cytokine production in vitro and in vivo.
    Heo Y, Parsons PJ, Lawrence DA.
    Toxicol Appl Pharmacol; 1996 May; 138(1):149-57. PubMed ID: 8658504
    [Abstract] [Full Text] [Related]

  • 4. In vivo the environmental pollutants lead and mercury induce oligoclonal T cell responses skewed toward type-2 reactivities.
    Heo Y, Lee WT, Lawrence DA.
    Cell Immunol; 1997 Aug 01; 179(2):185-95. PubMed ID: 9268502
    [Abstract] [Full Text] [Related]

  • 5. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12.
    Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M.
    J Immunol; 1997 Feb 15; 158(4):1541-50. PubMed ID: 9029088
    [Abstract] [Full Text] [Related]

  • 6. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.
    Bliss J, Van Cleave V, Murray K, Wiencis A, Ketchum M, Maylor R, Haire T, Resmini C, Abbas AK, Wolf SF.
    J Immunol; 1996 Feb 01; 156(3):887-94. PubMed ID: 8558014
    [Abstract] [Full Text] [Related]

  • 7. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
    DiIulio NA, Xu H, Fairchild RL.
    Eur J Immunol; 1996 Nov 01; 26(11):2606-12. PubMed ID: 8921946
    [Abstract] [Full Text] [Related]

  • 8. IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12.
    Lingnau K, Hoehn P, Kerdine S, Koelsch S, Neudoerfl C, Palm N, Ruede E, Schmitt E.
    J Immunol; 1998 Nov 01; 161(9):4709-18. PubMed ID: 9794401
    [Abstract] [Full Text] [Related]

  • 9. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA.
    J Rheumatol; 2000 May 01; 27(5):1128-35. PubMed ID: 10813277
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H, Choi TW, Ahn KS, Lee JY, Ham IH, Choi HY, Shim ES, Sohn NW.
    J Ethnopharmacol; 2009 May 04; 123(1):6-14. PubMed ID: 19429332
    [Abstract] [Full Text] [Related]

  • 11. Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies.
    Goedert S, Germann T, Hoehn P, Koelsch S, Palm N, Rüde E, Schmitt E.
    J Immunol; 1996 Jul 15; 157(2):566-73. PubMed ID: 8752903
    [Abstract] [Full Text] [Related]

  • 12. The paradoxical effects of lead in interferon-gamma knockout BALB/c mice.
    Gao D, Kasten-Jolly J, Lawrence DA.
    Toxicol Sci; 2006 Feb 15; 89(2):444-53. PubMed ID: 16280381
    [Abstract] [Full Text] [Related]

  • 13. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M, Falkner DH, Morel PA.
    J Leukoc Biol; 2005 Sep 15; 78(3):656-64. PubMed ID: 15961574
    [Abstract] [Full Text] [Related]

  • 14. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
    Nakamura T, Kamogawa Y, Bottomly K, Flavell RA.
    J Immunol; 1997 Feb 01; 158(3):1085-94. PubMed ID: 9013946
    [Abstract] [Full Text] [Related]

  • 15. Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitor.
    Claveau D, Chen SL, O'Keefe S, Zaller DM, Styhler A, Liu S, Huang Z, Nicholson DW, Mancini JA.
    J Pharmacol Exp Ther; 2004 Aug 01; 310(2):752-60. PubMed ID: 15082748
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells.
    Zhou W, Blackwell TS, Goleniewska K, O'Neal JF, Fitzgerald GA, Lucitt M, Breyer RM, Peebles RS.
    J Leukoc Biol; 2007 Mar 01; 81(3):809-17. PubMed ID: 17135575
    [Abstract] [Full Text] [Related]

  • 17. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. IV. Differential activation of human Th1 and Th2 lymphocytes and influence of the atopic status on lymphoma development.
    Coppola V, Veronesi A, Indraccolo S, Calderazzo F, Mion M, Minuzzo S, Esposito G, Mauro D, Silvestri B, Gallo P, Falagiani P, Amadori A, Chieco-Bianchi L.
    J Immunol; 1998 Mar 01; 160(5):2514-22. PubMed ID: 9498797
    [Abstract] [Full Text] [Related]

  • 18. Regulation of pulmonary T cell responses to inhaled antigen: role in Th1- and Th2-mediated inflammation.
    Lee SC, Jaffar ZH, Wan KS, Holgate ST, Roberts K.
    J Immunol; 1999 Jun 01; 162(11):6867-79. PubMed ID: 10352309
    [Abstract] [Full Text] [Related]

  • 19. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
    Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K.
    J Immunol; 1998 Oct 01; 161(7):3400-7. PubMed ID: 9759857
    [Abstract] [Full Text] [Related]

  • 20. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.
    Kim TS, DeKruyff RH, Rupper R, Maecker HT, Levy S, Umetsu DT.
    J Immunol; 1997 May 01; 158(9):4137-44. PubMed ID: 9126973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.